申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170247396A1
公开(公告)日:2017-08-31
The present invention provides compounds of Formula (I): wherein A and R
1
are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.